Javier F. Negron, PhD, Medical Strategist Proximyl Health, a company of The Agency Network at MJH Life Sciences, Brand Insights Contributor
Advertisement
Articles by Javier F. Negron, PhD, Medical Strategist Proximyl Health, a company of The Agency Network at MJH Life Sciences, Brand Insights Contributor
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Elicio Therapeutics’ Shares Drop Following Announcement of Phase II Trial Results
2
Pharma Roundup: FDA Approves Truqap Plus Abiraterone and Prednisone, FDA Approves Keytruda and Keytruda Qlex Each in Combination with Welireg
3
Partnering in Non-Opioids: Q&A with Dr. Edward Littler and Dave Watson
4
Pharmaceutical Executive Daily: FDA Approves Two Indications of Keytruda in Combination with Welireg
5